- $373.37m
- $265.57m
U.S. STOCKS ON THE MOVE-Teekay, Brenmiller Energy, JetBlue
U.S. STOCKS ON THE MOVE-Western Alliance Bancorp, Terns Pharma, Rezolute
Rezolute rises as FDA lifts partial clinical hold on blood sugar treatment
US FDA lifts partial clinical hold on Rezolute's low blood sugar treatment (updated)
US FDA lifts partial clinical hold on Rezolute's blood sugar treatment
Brief: Rezolute To Commence Study Start-Up Activities In US
Brief: Rezolute Files For Shelf Of Up To 4.5 Mln Shares By Certain Selling Stockholders
Brief: Rezolute Announces Exercise Of Underwriters’ Option To Purchase Additional Shares And Concurrent Private Placement
Brief: Rezolute Announces Closing Of Public Offering With Approximately $60 Mln In Gross Proceeds
U.S. STOCKS ON THE MOVE-Gold miners, Hasbro, VinFast
U.S. STOCKS ON THE MOVE-Zura Bio, MicroStrategy, Gold miners
U.S. STOCKS ON THE MOVE-Huntington, Adobe, Shopify
Rezolute tumbles on pricing stock offering
Brief: Rezolute Announces Pricing Of Public Offering Of $60 Mln Of Common Stock And Pre-Funded Warrants
Brief: Rezolute Announces Proposed Public Offering Of Common Stock And Pre-Funded Warrants
Rezolute slides after stock offering launch
Rezolute soars as eye disease drug meets main goal of mid-stage study
Brief: Rezolute Reports Positive Topline Results From Phase 2 Proof Of Concept Study Of Rz402
Rezolute Inc reports results for the quarter ended in March - Earnings Summary